Unipolar pacing in the presence of electromagnetic interference

• US 9,095,721 B2
• Filed: 11/18/2011
• Issued: 08/04/2015
• Est. Priority Date: 04/29/2011
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Stancer, Christopher C., Edmonson, Jonathan D., Ellingson, Michael L.
• Primary Examiner(s): Koharski, Christopher D
• Assistant Examiner(s): Patel, Natasha
• Application Number:
  US13/299,965
• Publication Number:
  US 20120277815A1
• Time in Patent Office: 1,355 Days
• Field of Search: 607/6, 607/7, 607/62, 607/28, 600/425
• US Class Current: 1/1
• CPC Class Codes: A61N 1/086 Magnetic resonance imaging [MRI] compatible leads
• CPC Class Codes: A61N 1/3718 Monitoring of or protection against external electromagnetic fields or currents

Abstract

An implantable medical system may include an implantable medical lead including at least one electrode and an implantable medical device. The implantable medical device comprises an electromagnetic interference (EMI) detection module that monitors for one or more particular characteristics of EMI. A control module is configured to control a therapy module to generate single stimulation pulses while operating the IMD in a first operating mode. In response to detecting the condition indicative of the presence of EMI, the control module switches the IMD from the first operating mode to a second operating mode and generates at least one group of two or more stimulation pulses in close proximity to one another in place of a single stimulation pulse while operating the IMD in the second operating mode.

Claims

1. A method comprising:

generating single stimulation pulses while operating an implantable medical device (IMD) in a first operating mode;

detecting a condition indicative of the presence of electromagnetic interference (EMI);

switching the IMD from the first operating mode to a second operating mode in response to detecting the condition indicative of the presence of EMI, wherein the second operating mode comprises an asynchronous pacing mode in which pacing therapy is delivered without regard to sensed electrical signals; and

generating at least one group of two or more stimulation pulses in close proximity to one another while operating the IMD in the second operating mode, wherein the two or more stimulation pulses of the group are within 110 milliseconds of one another.

2. The method of claim 1, wherein the two or more stimulation pulses of the group are within 5 milliseconds of one another.

3. The method of claim 1, wherein generating the group of two or more stimulation pulses comprises generating two or more stimulation pulses having amplitudes that are substantially the same as one another.

4. The method of claim 1, wherein detecting the condition indicative of the presence of EMI comprises detecting the condition indicative of the presence of EMI based on information provided by one or more sensors.

5. The method of claim 4, wherein detecting the condition indicative of the presence of EMI based on information provided by one or more sensors comprises detecting the condition indicative of the presence of EMI when the output provided by the one or more sensors indicates that the strength of a magnetic field exceeds a threshold strength.

6. The method of claim 1, wherein detecting the condition indicative of the presence of EMI comprises receiving a command via wireless telemetry that instructs the IMD to switch into the second operating mode.

7. The method of claim 1, further comprising suspending at least one of tachycardia detection, tachycardia therapy, fibrillation detection, fibrillation therapy, impedance measurements, or battery measurements while operating in the second operating mode.

8. The method of claim 1, further comprising:

detecting gradient magnetic fields while operating in the second operating mode; and

delivering unipolar pacing therapy as a function of the detected gradient magnetic fields.

9. The method of claim 8, further comprising:

determining whether a detected gradient magnetic field coincides with a timing of a stimulation pulse;

delivering a single stimulation pulse when the detected gradient magnetic field does not coincide with the timing of the stimulation pulse; and

delivering a group of two or more stimulation pulses when the detected gradient magnetic field does coincide with the timing of the stimulation pulse.

10. The method of claim 9, wherein determining whether the detected gradient magnetic field coincides with the timing of the desired stimulation pulse comprises:

monitoring the output of a gradient field detection module just prior to the desired stimulation pulse; and

determining that the gradient magnetic field coincides with the timing of the desired stimulation pulse if the gradient field is detected during the monitoring.

11. The method of claim 9, wherein determining whether the detected gradient magnetic field coincides with the timing of the desired stimulation pulse comprises determining that the gradient magnetic field coincides with the timing of the desired stimulation pulse if the gradient magnetic field and the desired stimulation pulse occur within a threshold period of time of one another.

12. The method of claim 11, wherein the threshold period of time is ten milliseconds.

13. An implantable medical system comprising:

an implantable medical lead including at least one electrode;

an implantable medical device comprising;

an electromagnetic interference (EMI) detection module that monitors for one or more particular characteristics of EMI;

a therapy module that delivers pacing therapy via the implantable medical lead;

a control module that controls the therapy module to generate single stimulation pulses while operating the IMD in a first operating mode, detects a condition indicative of EMI based on the one or more monitored characteristics, switches the IMD from the first operating mode to a second operating mode in response to detecting the condition indicative of the presence of EMI, and controls the therapy module to generate at least one group of two or more stimulation pulses within 110 milliseconds of one another while operating the IMD in the second operating mode; and

a gradient field detection module that detects gradient magnetic fields while operating in the second operating mode,

wherein the control module determines whether a detected gradient magnetic field coincides with a timing of a desired stimulation pulse, controls therapy module to generate a single stimulation pulse when the detected gradient magnetic field does not coincide with the timing of the desired stimulation pulse, and controls therapy module to generate the at least one group of two or more stimulation pulses when the detected gradient magnetic field does coincide with the timing of the desired stimulation pulse.

14. The system of claim 13, wherein the control module generates the two or more stimulation pulses of the group within 5 milliseconds of one another.

15. The system of claim 13, wherein the control module controls the therapy module to generate the two or more stimulation pulses of the group with amplitudes that are substantially the same as one another.

16. The system of claim 13, further comprising one or more sensors that generate an output as a function of the EMI, wherein the control module detects the condition indicative of the presence of EMI based on the output of the one or more sensors.

17. The system of claim 13, further comprising a communication module that receives communications from an external device, wherein the control module detects the condition indicative of the presence of EMI by receiving a command via wireless telemetry that instructs the IMD to switch into the second operating mode.

18. The system of claim 13, wherein the control module suspends at least one of tachycardia detection, tachycardia therapy, fibrillation detection, fibrillation therapy, impedance measurements, or battery measurements while operating in the second operating mode.

19. The system of claim 13, wherein the control module monitors the output of the gradient field detection module just prior to the desired stimulation pulse and determines that the gradient magnetic field coincides with the timing of the desired stimulation pulse if the gradient field is detected.

20. The system of claim 13, wherein the control module determines that the gradient magnetic field coincides with the timing of the desired stimulation pulse if the gradient magnetic field and the desired stimulation pulse occur within a threshold period of time of one another.

21. The system of claim 20, wherein the threshold period of time is ten milliseconds.

22. A computer-readable medium comprising instructions that, when executed, cause an implantable medical device (IMD) to:

generate single stimulation pulses while operating the IMD in a first operating mode;

detect a condition indicative of the presence of electromagnetic interference (EMI);

switch the IMD from the first operating mode to a second operating mode in response to detecting the condition indicative of the presence of EMI; and

generate a group of two or more stimulation pulses within 110 milliseconds of one another each time a pacing pulse is desired while operating the IMD in the second operating mode.

23. The computer-readable medium of claim 22, wherein the instructions to generate the group of two or more stimulation pulses comprises instructions to generate within 5 milliseconds of one another.

24. The computer-readable medium of claim 22, wherein the instructions to generate the group of two or more stimulation pulses while operating in the second operating mode comprise instructions to generate the two or more stimulation pulses of the group with substantially the same amplitude as one another.

25. The computer-readable medium of claim 22, wherein the instructions to detect the condition indicative of the presence of EMI comprise instructions to detect the condition indicative of the presence of EMI based on one of information provided by one or more sensors and a command via wireless telemetry that instructs the IMD to switch into the second operating mode.

26. The computer-readable medium of claim 22, further comprising instructions that, when executed, cause the IMD to suspend at least one of tachycardia detection, tachycardia therapy, fibrillation detection, fibrillation therapy, impedance measurements, or battery measurements while operating in the second operating mode.